πŸ‡ΊπŸ‡Έ FDA
Patent

US 10611768

P2X3 and/or P2X2/3 compounds and methods

granted A61PA61P11/00A61P11/06

Quick answer

US patent 10611768 (P2X3 and/or P2X2/3 compounds and methods) held by Asana BioSciences, LLC expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Asana BioSciences, LLC
Grant date
Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P25/00